Literature DB >> 2858917

Two types of somatostatin receptors differentiated by cyclic somatostatin analogs.

V T Tran, M F Beal, J B Martin.   

Abstract

Somatostatin receptors in rat brain, pituitary, and pancreas were labeled with two radioiodinated analogs of somatostatins 14 and 28. Two cyclic analogs of somatostatin, SMS201-995 and cyclo(Ala-Cys-Phe-D-Trp-Lys-Thr-Cys), showed biphasic displacement of binding to somatostatin receptors by these radioligands. In contrast, all other somatostatin analogs, including somatostatin-14, competed for the receptor sites with monophasic displacement of radioligand receptor binding. Thus two types of somatostatin receptors were identified. It was found that the pituitary and pancreas have predominantly one type of somatostatin receptor whereas the brain has both, and that different regions of the brain have various proportions of the two types. These findings suggest methods to characterize other types of somatostatin receptors subserving somatostatin's diverse physiological functions, including a potential role in cognitive function and extrapyramidal motor system control.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858917     DOI: 10.1126/science.2858917

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Expression cloning of a rat brain somatostatin receptor cDNA.

Authors:  F W Kluxen; C Bruns; H Lübbert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Molecular cloning and functional expression of a brain-specific somatostatin receptor.

Authors:  J F Bruno; Y Xu; J Song; M Berelowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.

Authors:  E S McKeen; W Feniuk; A D Michel; E J Kidd; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

5.  Further studies of the effects of somatostatin and related peptides in area CA1 of rabbit hippocampus.

Authors:  H E Scharfman; P A Schwartzkroin
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

Review 6.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

7.  Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors.

Authors:  S Boehm; H Betz
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

8.  Effect of somatostatin analog (SMS 201-995) on in vivo intestinal fluid transport in rats. A limited systemic effect.

Authors:  R N Fedorak; S L Allen
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

9.  Cloning and characterization of a fourth human somatostatin receptor.

Authors:  L Rohrer; F Raulf; C Bruns; R Buettner; F Hofstaedter; R Schüle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  Effects of acute and chronic desipramine treatment on somatostatin receptors in brain.

Authors:  E G Gheorvassaki; K Thermos; G Liapakis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.